Tumor derived mutations of protein tyrosine phosphatase receptor type k affect its function and alter sensitivity to chemotherapeutics in glioma
about
Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysisKnockdown of protein tyrosine phosphatase receptor U inhibits growth and motility of gastric cancer cells.NOTCH3 is a prognostic factor that promotes glioma cell proliferation, migration and invasion via activation of CCND1 and EGFR.Notch and TGF-β pathways cooperatively regulate receptor protein tyrosine phosphatase-κ (PTPRK) gene expression in human primary keratinocytes.Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1.Dual roles of protein tyrosine phosphatase kappa in coordinating angiogenesis induced by pro-angiogenic factors.Genetic alterations of protein tyrosine phosphatases in human cancers.Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell linesProtein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling
P2860
Q26865296-23D80E8E-6631-4FD3-9730-EE7A0B232BE3Q34371330-D9AA8E3C-36E1-4A93-AABD-30A7017A2BE1Q35021721-D4226B18-4D9E-43AC-8BCB-B94CD756E6AFQ35171032-116A9905-ECA6-4D2B-BD74-D1B6B28D57FDQ37441728-2FD14B72-4956-479D-AE87-F458A24C74DFQ37718673-8110E430-F611-4013-8B86-013C49F19190Q38255066-66D23D8F-5E03-4244-B3A1-18FE9278266BQ38700421-B993D9AE-6574-4F4D-9893-449014565B2FQ48753389-5956B015-A661-41D9-9408-75548DCCDCDBQ58749617-614CE025-8F43-4C10-A53D-550EADE52767
P2860
Tumor derived mutations of protein tyrosine phosphatase receptor type k affect its function and alter sensitivity to chemotherapeutics in glioma
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Tumor derived mutations of pro ...... to chemotherapeutics in glioma
@ast
Tumor derived mutations of pro ...... to chemotherapeutics in glioma
@en
Tumor derived mutations of pro ...... to chemotherapeutics in glioma
@en-gb
Tumor derived mutations of pro ...... to chemotherapeutics in glioma
@nl
type
label
Tumor derived mutations of pro ...... to chemotherapeutics in glioma
@ast
Tumor derived mutations of pro ...... to chemotherapeutics in glioma
@en
Tumor derived mutations of pro ...... to chemotherapeutics in glioma
@en-gb
Tumor derived mutations of pro ...... to chemotherapeutics in glioma
@nl
altLabel
Tumor Derived Mutations of Pro ...... to Chemotherapeutics in Glioma
@en
prefLabel
Tumor derived mutations of pro ...... to chemotherapeutics in glioma
@ast
Tumor derived mutations of pro ...... to chemotherapeutics in glioma
@en
Tumor derived mutations of pro ...... to chemotherapeutics in glioma
@en-gb
Tumor derived mutations of pro ...... to chemotherapeutics in glioma
@nl
P2093
P2860
P1433
P1476
Tumor derived mutations of pro ...... to chemotherapeutics in glioma
@en
P2093
Maha S Al-Keilani
Mahfoud Assem
Mohammad A Y Alqudah
Supreet Agarwal
Timothy C Ryken
Zita A Sibenaller
P2860
P304
P356
10.1371/JOURNAL.PONE.0062852
P407
P577
2013-01-01T00:00:00Z